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ABSTRACT 
Proteins are the main workhorses of biological functions in a cell, a 
tissue, or an organism. Identification and quantification of proteins in 
a given sample, e.g. a cell type under normal/disease conditions, are 
fundamental tasks for the understanding of human health and 
disease. In this paper, we present DeepNovo, a deep learning-based 
tool to address the problem of protein identification from tandem 
mass spectrometry data. The idea was first proposed in the context of 
de novo peptide sequencing [1] in which convolutional neural 
networks and recurrent neural networks were applied to predict the 
amino acid sequence of a peptide from its spectrum, a similar task to 
generating a caption from an image. We further develop DeepNovo to 
perform sequence database search, the main technique for peptide 
identification that greatly benefits from numerous existing protein 
databases. We combine two modules de novo sequencing and 
database search into a single deep learning framework for peptide 
identification, and integrate de Bruijn graph assembly technique to 
offer a complete solution to reconstruct protein sequences from 
tandem mass spectrometry data. This paper describes a 
comprehensive protocol of DeepNovo for protein identification, 
including training neural network models, dynamic programming 
search, database querying, estimation of false discovery rate, and de 
Bruijn graph assembly. Training and testing data, model 
implementations, and comprehensive tutorials in form of IPython 
notebooks are available in our GitHub repository 
(https://github.com/nh2tran/DeepNovo).  
INTRODUCTION 
While most human cells carry the same genome regardless of their types or 
developmental stages, the proteome, the complete set of proteins in a given cell, 
is much more dynamic due to differential gene expression, alternative splicing, or 
post-translational modifications. Proteomics is the large-scale study of the 
proteome expressed in a given biological sample. Liquid chromatography 
coupled with tandem mass spectrometry (LC-MS/MS) is the current state-of-the-
art technology for protein characterization in proteomics [2-3]. In those 
experiments, proteins are first digested into peptides by different enzymes 
(simply speaking, a long amino acid sequence is cleaved into several short 
subsequences), and the peptides are subsequently analyzed by LC-MS/MS 
instruments. Typical analysis workflows of LC-MS/MS data, e.g. PEAKS, 
OpenMS, include peptide feature detection and quantification from an LC-MS 
map, peptide identification from MS/MS spectra, and protein profiling [4-5].  
In this paper, we focus on the problem of protein identification that includes (i) 
predicting peptide sequences from MS/MS spectra and (ii) assembling those 
peptides back to original protein sequences. The task of peptide identification is 
to predict the amino acid sequence of a peptide given its spectrum and its mass 
(Figure 1). There are 20 standard amino acids and their names are often 
abbreviated by single alphabet letters. Each amino acid has its own molecule 
mass and the peptide mass is the total mass of its amino acids plus its N-
terminal and C-terminal. A spectrum is a collection of (mass, intensity) of ions 
resulted from the fragmentation at the peptide backbone between any two 
adjacent amino acids. For example, consider the peptide 
“LHAVTLNNVAEANFFK” and its annotated spectrum in Figure 1. A fragmentation 
between “A” and “V” at the 3rd and 4th positions results in two fragments “LHA-” 
and “-VTLNNVAEANFFK” that correspond to two ions b3 and y13, respectively. 
Note that b-ions are indexed from the left to the right of the amino acid sequence 
and y-ions are indexed in the opposite direction. Similarly, a fragmentation 
between “V” and “T” at the 4th and 5th positions results in two fragments “LHAV-” 
and “-TLNNVAEANFFK” and two ions b4 and y12. More importantly, the mass 
difference between b3 and b4 as well as the mass difference between y12 and y13 
match the theoretical molecule mass of the amino acid “V”. Hence, given an 
unannotated spectrum, one could try to iteratively annotate the b-ion and/or y-ion 
series and predict the corresponding amino acid sequence. The total mass of 
predicted amino acids should also match the given peptide mass. 
However, there are multiple computational challenges. While b-ion and y-ion 
series are often observed with strong signals, peptide fragmentation actually may 
produce several types of ions including a, b, c, x, y, z, internal cleavage and 
immonium ions, as well as their sub-types [3]. Different types of ions have their 
own intensity distributions and they always mix up together in both directions with 
respect to the peptide sequence (Figure 1). There are plenty of noise in addition 
to the real signals, while at the same time, there are also real ions missing from 
the spectrum, especially for fragmentation near the two terminals of the peptide 
sequence. Furthermore, we need to take into account measurement errors of 
mass spectrometers for both peptide and its fragment ions. Those challenges 
exponentially explode the search space, making it infeasible to identify the right 
peptide for a spectrum. 
There are two key techniques to tackle the problem of peptide identification. If the 
species information of the biological sample is given, e.g. human, one could 
search the spectrum against a specific protein sequence database of that 
species. In this database search problem, the search space is first reduced to a 
finite set of candidate sequences by filtering based on species and peptide mass. 
Each candidate is then compared to the spectrum based on a match-scoring 
function to select the optimum sequence that best fits the fragment ions in the 
spectrum [6]. If such database information is not available, this becomes a de 
novo sequencing problem, which is much more complicated. Dynamic 
programming algorithms are often required to explore the huge search space to 
find the sequence that maximizes their scoring functions [7]. In general, the two 
techniques, de novo sequencing and database search, share the same idea of 
using some scoring functions to match a spectrum against a peptide, and differ 
by their search strategies. Another useful information for both techniques is the 
digestion enzymes because they often cleave proteins with high specificity. For 
instance, trypsin cuts the peptide bond to the C-terminal side of lysine (“K”) and 
arginine (“R”), and hence, most peptides from trypsin digestion have “K” or “R” at 
the end of their sequence (Figure 1). 
Once the peptides have been identified, it is essential to assemble them back to 
original protein sequences. This problem is similar to genome or transcriptome 
assembly from high-throughput sequencing short reads [8]. While protein 
sequences are much shorter than genome sequences, there are still many 
obstacles including low coverage, sequencing errors and ambiguities, and the 
complexity of protein mixture in the biological sample. Assembly algorithms 
based on overlapping sequences and confidence scores of predicted peptides 
are the keys to solve this problem [9]. 
Our study offers a novel deep learning-based method for peptide identification 
and presents a paradigm shift from algorithm-centric to data-centric approach 
that greatly benefits from the increasing massive amount of data in proteomics. 
In the next section, we describe the details of DeepNovo algorithms for protein 
identification. 
METHODS 
DeepNovo Scoring Function 
The scoring function of DeepNovo was first proposed in [1]. The idea is to 
sequence the peptide by iteratively predicting one amino acid after another and 
the prediction of the next amino acid depends on the output of previous steps 
(see Figure 1 in [1]). Mathematically speaking, we calculate a series of 
conditional probabilities. For example, the score of the sequence “PEPTIDE” 
given its spectrum is calculated as in the following equation: 
𝑃𝑟𝑜𝑏(𝑃𝐸𝑃𝑇𝐼𝐷𝐸 | 𝑠𝑝𝑒𝑐𝑡𝑟𝑢𝑚) = 𝑃𝑟𝑜𝑏(𝑃 | 𝑠𝑝𝑒𝑐𝑡𝑟𝑢𝑚)
∗   𝑃𝑟𝑜𝑏(𝐸 | 𝑃, 𝑠𝑝𝑒𝑐𝑡𝑟𝑢𝑚)
∗   𝑃𝑟𝑜𝑏(𝑃 | 𝑃𝐸, 𝑠𝑝𝑒𝑐𝑡𝑟𝑢𝑚)
∗   𝑃𝑟𝑜𝑏(𝑇 | 𝑃𝐸𝑃, 𝑠𝑝𝑒𝑐𝑡𝑟𝑢𝑚)
∗   𝑃𝑟𝑜𝑏(𝐼  | 𝑃𝐸𝑃𝑇, 𝑠𝑝𝑒𝑐𝑡𝑟𝑢𝑚)
∗   𝑃𝑟𝑜𝑏(𝐷 | 𝑃𝐸𝑃𝑇𝐼, 𝑠𝑝𝑒𝑐𝑡𝑟𝑢𝑚)
∗   𝑃𝑟𝑜𝑏(𝐸 | 𝑃𝐸𝑃𝑇𝐼𝐷, 𝑠𝑝𝑒𝑐𝑡𝑟𝑢𝑚)          Equation (1) 
In the implementation, we actually use the log of probability as the score, and the 
score of a sequence is the sum of its amino acids’ scores normalized by its 
length. Each conditional probability is computed based on two classification 
models that use the previous output as a prefix to predict the next amino acid. 
The first model uses a convolutional neural network (CNN) [10-11] to learn 
features of the intensity distribution of fragment ions in the spectrum. The second 
model uses a long short-term memory (LSTM) recurrent neural network (RNN) to 
learn sequence patterns of the peptide [12-15]. The final output of those neural 
networks is a probability distribution over 20 classes, i.e. amino acid letters, 
which are used to compute equation (1). 
DeepNovo Database Search 
Knowing the species of the biological sample, we first collect its protein 
sequences from the UniProt database [16]. We use the taxonomy view to select 
all strains of the species and download their Swiss-Prot sequences (since those 
sequences have been carefully annotated and reviewed). Then we perform in 
silico digestion of protein sequences into peptides using the Pyteomics package 
[17], where the cleavage rules are determined by the enzymes used in the 
biological experiments. Other options including maximum number of missed 
cleavages or minimum peptide length are also available. We obtain a list of 
peptide sequences and compute their theoretical mass which altogether serve as 
the database for our search. 
Given each pair of spectrum and experimental peptide mass from the input data, 
we need to query them against the database to identify the best-match peptide 
sequence. The experimental peptide mass is first used to filter the database to a 
set of candidate sequences with approximately same theoretical mass, subject to 
a pre-determined error tolerance. The error tolerance is often measured in part-
per-million (ppm) and hence is proportional to the experimental peptide mass 
rather than an absolute amount. Each candidate sequence is then scored against 
the spectrum using equation (1). It should be noted that while equation (1) shows 
the calculation in the forward direction, we also implement backward direction 
and sum up the score of both directions. The benefits of bi-directional 
sequencing are manifold. First, it reduces the chance of losing information due to 
missing fragment ions near the two terminals. Second, it allows the LSTM model 
to learn sequence patterns around the prediction position rather than from one 
side. Last but not least, using multiple ensembles of the same neural network 
model often increases its accuracy. The highest-scoring candidate is finally 
selected as the predicted peptide sequence. 
DeepNovo De novo Sequencing 
When database information is not available, we have to perform de novo 
sequencing. This is a global optimization problem where we need to find a 
peptide sequence such that its total mass is approximately equal to the 
experimental peptide mass and its matching score against the spectrum is 
maximized. Unlike database search, it is not possible to reduce the search space 
to a finite set of candidate sequences. We apply beam search, a heuristic search 
algorithm that explores a fixed number of top candidate sequences at each 
iteration. Note that the score based on equation (1) is now computed on partial 
sequences during the iterative process, and the final predicted sequence is not 
guaranteed to be the global optimum. The beam search is also accompanied by 
an off-line dynamic programming algorithm to keep comparing the mass of 
predicted sequences and the experimental peptide mass during the iterative 
search. This procedure also helps to filter out those amino acids that do not fit 
the experimental peptide mass. We also apply bi-directional sequencing here, 
but in this case, the forward pass and the backward pass may not necessarily 
produce the same sequence. Overall, de novo sequencing is more heuristic and 
hence less accurate then database search, but this technique can identify novel 
sequences that do not exist in databases. 
DeepNovo Hybrid Solution 
Since we formulate both techniques, database search and de novo sequencing, 
in the same iterative sequencing approach and use the same scoring function, it 
is possible to merge them into a hybrid solution. The idea is that if a peptide is 
novel and does not exist in databases, a de novo sequence is likely to have 
better score than the highest-scoring candidate from database search. This is 
often not the case for existing methods due to inconsistencies in handling those 
two problems (e.g. database search tools often incorporate more features into 
their scoring functions than de novo sequencing tools). 
RESULTS 
Performance Evaluation 
We evaluated the accuracy of DeepNovo de novo sequencing and database 
search on a dataset of Saccharomyces cerevisiae proteome [18]. The data was 
acquired from Thermo Scientific Orbitrap Fusion instrument with the Higher-
energy Collisional Dissociation (HCD) technique. We first used PEAKS DB 
software (version 8.0, [4]) to search against the UniProt database with the yeast 
taxonomy (7,904 protein sequences in total). Other settings include Trypsin 
digestion, maximum two missed cleavages and one non-specific cleavage, 
precursor mass tolerance 20 ppm, fragment ion mass tolerance 0.5 Dalton, fixed 
modification Carbamidomethylation (C), variable modifications Oxidation (M) and 
Deamidation (NQ), and false discovery rate (FDR) of 1%. The peptide sequences 
identified from PEAKS DB search were assigned to the corresponding MS/MS 
spectra and were then used as ground-truth for training and testing the accuracy 
of DeepNovo. There were 347,047 peptide-spectrum matches in total, 90% of 
which were used for training, 5% for validation, and 5% for testing. We calculated 
the total recall as the ratio of the total number of correctly predicted amino acids 
over the total length of target peptide sequences. We also calculated the recall at 
the peptide level, i.e. the fraction of target peptide sequences that were fully 
correctly predicted. Due to the peptide mass constraint, predicted peptide 
sequences tend to have similar lengths to the corresponding targets, so precision 
is often very close to recall and we did not report it here. 
Table 1 show the de novo sequencing and database search results of DeepNovo. 
We also included the de novo sequencing results of PEAKS. It should be noted 
that PEAKS database search results were used as ground-truth, so the 
performance of DeepNovo would not exceed that of PEAKS. A more accurate 
comparison should include several database search tools and use their 
consensus as ground-truth. The preliminary results here show that DeepNovo 
identified 89.8% of peptides from PEAKS database search. We further looked 
into details of the other 10.2% where DeepNovo and PEAKS disagreed. We 
found multiple evidences that DeepNovo predicted high-quality alternative 
peptides to complement PEAKS results. Three examples are shown in Figure 2. 
Interestingly, in the last two examples, DeepNovo predicted the same sequences 
as PEAKS de novo sequencing, while PEAKS database search results were 
different.  
  
Table and Figure Legends 
Table 1. The recall of PEAKS and DeepNovo at the amino acid level and the 
peptide level. 
 PEAKS 
de novo 
DeepNovo 
de novo 
DeepNovo 
database 
Amino acid recall 57.4% 74.3% 89.9% 
Peptide recall 25.7% 61.7% 89.8% 
 
Figure 1. An example of peptide, spectrum and annotated fragment ions.  
Figure 2. DeepNovo predicts high-quality alternative peptides to PEAKS results.  
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